Emerging Biotech
AvenCell Secures Up to $40 Million AMED Grant to Advance Dual-Antigen Allogeneic CAR-T Therapy
AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapie...
July 02, 2025 | News
HanchorBio Licenses Novel CD47 Fusion Protein HCB101 to Henlius in $200 Million+ Regional Deal
HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, annou...
July 02, 2025 | News
SineuGene Therapeutics Receives FDA Orphan Drug Designation for Gene Therapy SNUG01 in ALS
SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug A...
June 27, 2025 | News
Duke Street Bio Secures FDA Fast Track Designation for DSB2455 in TNBC-Related Brain Metastases
Duke Street Bio, a clinical-stage biotechnology company focused on precision oncology, announced that the U.S. Food and Drug Administration (FDA) has...
June 25, 2025 | News
CanSinoBIO’s iPneucia® Vaccine Targets Deadly Pneumococcal Threat in Chinese Children with Precision and Safety
Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single ...
June 23, 2025 | News
Clarity and SpectronRx Sign US Manufacturing Deal for 64Cu-SAR-bisPSMA to Expand Access for Australia and the US
Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA. SpectronRx's facility in Indiana will...
June 18, 2025 | News
Reacta Healthcare Completes First Pharmaceutical-Grade Production of Egg and Milk Challenge Meals
1st production of pharmaceutical grade egg and milk challenge meals Product portfolio of challenge meals now includes peanut, milk and egg Innovat...
June 13, 2025 | News
Visterra Licenses Nona Biosciences’ HCAb Harbour Mice® Platform to Advance Autoimmune Biotherapeutics
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreeme...
June 13, 2025 | News
Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for Tenosynovial Giant Cell Tumor
Abbisko Therapeutics Co., Ltd. announced that the China National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) f...
June 11, 2025 | News
Insilico Medicine and AWS Bring Nach01 Generative AI Model for Drug Discovery to Global Researchers via AWS Marketplace
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), announced the recent release of its Nach...
June 11, 2025 | News
Alamar Biosciences, Gates Ventures, and Alzheimer's Disease Data Initiative Launch Global Effort to Build Largest Plasma Proteome Atlas for Alzheimer’s
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates ...
June 11, 2025 | News
Harrow Secures Exclusive U.S. Rights to BYQLOVI for Post-Surgical Eye Care Following FDA Approval
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today a...
June 10, 2025 | News
Neowise Licenses TCR Technology to BeOne Medicines for Off-the-Shelf iPSC-Based Cell Therapy Development
Neowise Biotechnology ("Neowise"), a pioneering company focused on the development of TCR-T cell therapies for solid tumors, announced today that it has en...
June 10, 2025 | News
VivaVision Receives Positive FDA Feedback on VVN461LD Phase 2 Trial for Ocular Inflammation
VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today t...
June 10, 2025 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
